Silence Therapeutics closes $201M public offering of ADSs Aug 14, 2026 04:55PM
Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs Aug 14, 2026 04:55PM
Silence Therapeutics prices $175 million public offering at $13.50 per ADS Aug 11, 2026 11:20PM
Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering Aug 11, 2026 11:20PM
Silence Therapeutics launches $150 million ADS public offering Aug 10, 2026 04:01PM


Aug 10, 2026 04:01PM Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares
Jun 24, 2026 06:06AM Cantor Fitzgerald Starts Silence Therapeutics (SLN) at Overweight
Sep 26, 2018 02:00AM Silence Therapeutics to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference